Physician

Todd N Adkins, M.D.

According to 2025 Medicare claims, Todd Adkins, M.D. (NPI: 1629056502) practices allergy/immunology in the Jackson, MS market, with the plurality of this provider's patient population coming from Rankin, MS. This provider's primary affiliated billing organization is MISSISSIPPI ASTHMA & ALLERGY CLINIC PA (NPI: 1902882251; TIN: 640502151) and primary practice location at 39216-4829.

Adkins' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 685 traditional Medicare patients, billed 52,509 HCPCS/CPT codes, and received $1,296,592 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,616 prescription claims across 754 beneficiaries totaling $979,957 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 138 claims. Open Payments data shows 137 records totaling $18,379. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $140,014 to $1,296,592. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $277,463 to $979,957. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $1,491 to $2,015.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	580	14,622	$140,014
2016	622	14,984	$147,747
2017	628	14,240	$136,636
2018	641	16,020	$160,442
2019	677	21,511	$275,504
2020	640	31,532	$551,679
2021	655	35,424	$720,334
2022	683	41,724	$845,932
2023	667	47,323	$1,015,961
2024	685	52,509	$1,296,592

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	436	3,835	$277,463
2016	469	4,200	$324,884
2017	473	4,656	$372,168
2018	505	4,731	$398,596
2019	557	4,819	$851,278
2020	576	5,627	$1,196,547
2021	623	5,983	$878,833
2022	646	5,843	$595,045
2023	677	6,316	$787,174
2024	754	7,616	$979,957

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	116	$1,609
2016	N/R	55	$683
2017	N/R	84	$80,985
2018	N/R	141	$142,307
2019	11	215	$76,528
2020	N/R	86	$957
2021	N/R	93	$1,465
2022	N/R	90	$920
2023	N/R	143	$69,469
2024	N/R	138	$157,420

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	378	606	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	221	246	$55
94010	Test to measure expiratory airflow and volume	235	359	$17
95165	Professional service for preparation and provision of 1 or more antigens	250	5,825	$9
95115	Professional service for single injection of allergen	130	2,080	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	297	12,030	$251,439
Dupixent Pen	Dupilumab	48	1,344	$179,916
Xolair	Omalizumab	46	1,288	$105,008
Breo Ellipta	Fluticasone/Vilanterol	151	5,790	$73,936
Nucala	Mepolizumab	16	448	$58,148

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	16	$155,486
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	19	$1,136
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	22	$388
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	19	$239
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	N	N/R	16	$63

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	137	$18,379	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Todd N. Adkins, M.D.?

Tedicare shows public-source Medicare data for Todd N. Adkins, M.D. (NPI 1629056502), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Todd N. Adkins, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Todd N. Adkins, M.D.?

Todd N. Adkins, M.D. is linked to MISSISSIPPI ASTHMA & ALLERGY CLINIC PA (billing NPI 1902882251) in the available physician profile data.

Does Todd N. Adkins, M.D. have Open Payments data?

Todd N. Adkins, M.D. has 137 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.